Literature DB >> 23885965

Current estimate of Down Syndrome population prevalence in the United States.

Angela P Presson1, Ginger Partyka, Kristin M Jensen, Owen J Devine, Sonja A Rasmussen, Linda L McCabe, Edward R B McCabe.   

Abstract

OBJECTIVE: To calculate a reliable estimate of the population prevalence of Down syndrome in the US. STUDY
DESIGN: The annual number of births of infants with Down syndrome were estimated by applying published birth prevalence rates of Down syndrome by maternal age to US data from the Centers for Disease Control and Prevention for the years for which births by maternal age were available (1940-2008). Death certificate data for persons with Down syndrome were available for the years 1968-2007. We estimated the number of people with Down syndrome on January 1, 2008, using a life table approach based on proportions of deaths by age. Monte Carlo sampling was used to create 90% uncertainty intervals (UIs) for our estimates.
RESULTS: We estimated the January 1, 2008, population prevalence of Down syndrome as approximately 250700 (90% UI, 185900-321700) based on proportions of deaths by age from the most recent 2 years (2006-2007) of death certificate data. This estimate corresponds to a prevalence of 8.27 people with Down syndrome per 10000 population (90% UI, 6.14-10.62).
CONCLUSION: Our estimate of Down syndrome prevalence is roughly 25%-40% lower than estimates based solely on current birth prevalence. The results presented here can be considered a starting point for facilitating policy and services planning for persons with Down syndrome.
Copyright © 2013 Mosby, Inc. All rights reserved.

Entities:  

Keywords:  CDC; Centers for Disease Control and Prevention; UI; Uncertainty interval

Mesh:

Year:  2013        PMID: 23885965      PMCID: PMC4445685          DOI: 10.1016/j.jpeds.2013.06.013

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  20 in total

1.  Results of surgical treatment of congenital heart defects in children with Down's syndrome.

Authors:  E Malec; T Mroczek; J Pajak; K Januszewska; E Zdebska
Journal:  Pediatr Cardiol       Date:  1999 Sep-Oct       Impact factor: 1.655

Review 2.  Termination rates after prenatal diagnosis of Down syndrome, spina bifida, anencephaly, and Turner and Klinefelter syndromes: a systematic literature review. European Concerted Action: DADA (Decision-making After the Diagnosis of a fetal Abnormality).

Authors:  C Mansfield; S Hopfer; T M Marteau
Journal:  Prenat Diagn       Date:  1999-09       Impact factor: 3.050

3.  Updated National Birth Prevalence estimates for selected birth defects in the United States, 2004-2006.

Authors:  Samantha E Parker; Cara T Mai; Mark A Canfield; Russel Rickard; Ying Wang; Robert E Meyer; Patrick Anderson; Craig A Mason; Julianne S Collins; Russell S Kirby; Adolfo Correa
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2010-09-28

4.  Estimation of the contribution of non-assisted reproductive technology ovulation stimulation fertility treatments to US singleton and multiple births.

Authors:  Laura A Schieve; Owen Devine; Coleen A Boyle; Joann R Petrini; Lee Warner
Journal:  Am J Epidemiol       Date:  2009-10-23       Impact factor: 4.897

5.  Rates of Down syndrome at livebirth by one-year maternal age intervals in studies with apparent close to complete ascertainment in populations of European origin: a proposed revised rate schedule for use in genetic and prenatal screening.

Authors:  C A Hecht; E B Hook
Journal:  Am J Med Genet       Date:  1996-04-24

Review 6.  Health inequity in children and youth with chronic health conditions.

Authors:  Jay G Berry; Sheila Bloom; Susan Foley; Judith S Palfrey
Journal:  Pediatrics       Date:  2010-12       Impact factor: 7.124

7.  National estimates and race/ethnic-specific variation of selected birth defects in the United States, 1999-2001.

Authors:  Mark A Canfield; Margaret A Honein; Nataliya Yuskiv; Jian Xing; Cara T Mai; Julianne S Collins; Owen Devine; Joann Petrini; Tunu A Ramadhani; Charlotte A Hobbs; Russell S Kirby
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2006-11

8.  Mortality associated with Down's syndrome in the USA from 1983 to 1997: a population-based study.

Authors:  Quanhe Yang; Sonja A Rasmussen; J M Friedman
Journal:  Lancet       Date:  2002-03-23       Impact factor: 79.321

9.  Prevalence of down syndrome among children and adolescents in metropolitan Atlanta.

Authors:  Lilah M Besser; Mikyong Shin; James E Kucik; Adolfo Correa
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2007-11

10.  Prevalence of Down syndrome among children and adolescents in 10 regions of the United States.

Authors:  Mikyong Shin; Lilah M Besser; James E Kucik; Chengxing Lu; Csaba Siffel; Adolfo Correa
Journal:  Pediatrics       Date:  2009-12       Impact factor: 7.124

View more
  81 in total

1.  DS-Connect: A Promising Tool to Improve Lives and Engage Down Syndrome Communities Worldwide.

Authors:  Emmanuel K Peprah; Melissa A Parisi; Lisa Kaeser; Sujata Bardhan; MaryLou Oster-Granite; Yvonne T Maddox
Journal:  Glob Heart       Date:  2015-08-11

2.  Addressing Health Disparities in Adults with Developmental Disabilities.

Authors:  Andrea S Videlefsky; Jeffrey M Reznik; Janice T Nodvin; Harry J Heiman
Journal:  Ethn Dis       Date:  2019-06-13       Impact factor: 1.847

Review 3.  Improving Memory and Cognition in Individuals with Down Syndrome.

Authors:  Michael S Rafii
Journal:  CNS Drugs       Date:  2016-07       Impact factor: 5.749

4.  Alzheimer-Related Cerebrovascular Disease in Down Syndrome.

Authors:  Patrick J Lao; José Gutierrez; David Keator; Batool Rizvi; Arit Banerjee; Kay C Igwe; Krystal K Laing; Mithra Sathishkumar; Fahmida Moni; Howard Andrews; Sharon Krinsky-McHale; Elizabeth Head; Joseph H Lee; Florence Lai; Michael A Yassa; H Diana Rosas; Wayne Silverman; Ira T Lott; Nicole Schupf; Adam M Brickman
Journal:  Ann Neurol       Date:  2020-10-09       Impact factor: 10.422

5.  Cause of death in adults with Down syndrome in the United States.

Authors:  Scott D Landes; J Dalton Stevens; Margaret A Turk
Journal:  Disabil Health J       Date:  2020-06-10       Impact factor: 2.554

6.  Germline 16p11.2 Microdeletion Predisposes to Neuroblastoma.

Authors:  Laura E Egolf; Zalman Vaksman; Gonzalo Lopez; Jo Lynne Rokita; Apexa Modi; Patricia V Basta; Hakon Hakonarson; Andrew F Olshan; Sharon J Diskin
Journal:  Am J Hum Genet       Date:  2019-08-29       Impact factor: 11.025

Review 7.  Cognitive Impairment, Neuroimaging, and Alzheimer Neuropathology in Mouse Models of Down Syndrome.

Authors:  Eric D Hamlett; Heather A Boger; Aurélie Ledreux; Christy M Kelley; Elliott J Mufson; Maria F Falangola; David N Guilfoyle; Ralph A Nixon; David Patterson; Nathan Duval; Ann-Charlotte E Granholm
Journal:  Curr Alzheimer Res       Date:  2016       Impact factor: 3.498

8.  Association between Physical Activity and Adiposity in Adolescents with Down Syndrome.

Authors:  E Andrew Pitchford; Chelsea Adkins; Rebecca E Hasson; Joseph E Hornyak; Dale A Ulrich
Journal:  Med Sci Sports Exerc       Date:  2018-04       Impact factor: 5.411

9.  Prevalence of Aging, Dementia, and Multimorbidity in Older Adults With Down Syndrome.

Authors:  Eleonore Bayen; Katherine L Possin; Yingjia Chen; Laurent Cleret de Langavant; Kristine Yaffe
Journal:  JAMA Neurol       Date:  2018-11-01       Impact factor: 18.302

10.  Cross-Sectional Trajectories of Mental State Language Development in Children With Down Syndrome.

Authors:  Marie Moore Channell
Journal:  Am J Speech Lang Pathol       Date:  2020-04-14       Impact factor: 2.408

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.